United Therapeutics Corporation

UTHR | NASDAQ

Price Alert Chart Builder DCF Calculator

$493.10

-$1.53 (-0.31%)

At close: Sep 21, 2026, 4:00 PM ET

$492.77

-$0.33 (-0.07%)

Pre-market: Sep 22, 2026, 5:41 AM ET

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Income Statement Balance Sheet Cashflow Statement Ratios

Annual Quarterly TTM

Fiscal Year Period Ending	FY 2025 Dec 30, 2025	FY 2024 Dec 30, 2024	FY 2023 Dec 30, 2023	FY 2022 Dec 30, 2022	FY 2021 Dec 30, 2021	FY 2020 Dec 30, 2020
Revenue	3.18B	2.88B	2.33B	1.94B	1.69B	1.48B
Cost of Revenue	384.4M	309.7M	257.5M	146.7M	122.5M	108.1M
Gross Profit	2.8B	2.57B	2.07B	1.79B	1.56B	1.38B
Operating Income	1.52B	1.38B	1.18B	979.7M	555.9M	593.6M
Interest Income	192M	199.1M	162.7M	45.2M	16.7M	28.6M
Pretax Income	1.71B	1.54B	1.27B	950.6M	593.9M	638.9M
Net Income	1.33B	1.2B	984.8M	727.3M	475.8M	514.8M
Selling & General & Admin	731.1M	638.6M	477.1M	487M	467M	423.9M
Research & Development	550M	481M	408M	322.9M	540.1M	357.7M
Other Expenses	n/a	71.1M	n/a	n/a	n/a	n/a
Operating Expenses	1.28B	1.19B	885.1M	809.9M	1.01B	781.6M
Interest Expense	19.5M	42.9M	59.3M	32.4M	18.6M	23.5M
Selling & Marketing Expenses	118.6M	96.3M	81.8M	70.8M	64.4M	54.9M
Cost & Expenses	1.67B	1.5B	1.14B	956.6M	1.13B	889.7M
Income Tax Expense	379.2M	343.9M	289.5M	223.3M	118.1M	124.1M
Shares Outstanding (Basic)	44.3M	45.2M	46.8M	45.5M	44.9M	44.2M
Shares Outstanding (Diluted)	47.9M	48.5M	49.7M	48.5M	47.3M	44.6M
EPS (Basic)	30.13	26.44	21.04	15.98	10.60	11.65
EPS (Diluted)	27.86	24.64	19.81	15	10.06	11.54
EBITDA	1.82B	1.65B	1.39B	1.04B	736.8M	646.3M
EBIT	1.73B	1.58B	1.33B	989M	686.9M	596.4M
Depreciation & Amortization	85.6M	72.5M	53.2M	51.3M	49.9M	49.9M